Branch of National Clinical Research Center for Metabolic Disease, Hubei, Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
BMC Med Genomics. 2021 May 10;14(1):126. doi: 10.1186/s12920-021-00896-0.
Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) is a rare form of adrenal Cushing's syndrome. The slowly progressing expansion of bilateral adrenal tissues usually persists for dozens of years, leading to delayed onset with severe conditions due to chronic mild hypercortisolism. About 20-50% cases were found to be caused by inactivating mutation of armadillo repeat-containing protein 5 (ARMC5) gene.
A 51-year-old man was admitted for severe diabetes mellitus, resistant hypertension, centripedal obesity and edema. PBMAH was diagnosed after determination of adrenocorticotropic hormone and cortisol levels, dexamethasone suppression tests and abdominal contrast-enhanced CT scanning. The metabolic disorders of the patient remarkably improved after sequentially bilateral laparoscopic adrenalectomy combined with hormone replacement. Sanger sequencing showed germline nonsense mutation of ARMC5 c.967C>T (p.Gln323Ter). The second somatic missense mutation of ARMC5 was detected in one out of two resected nodules, reflecting the second-hit model of tumorigenesis. Routine genetic testing in his apparently healthy offspring showed one of two daughters and one son harbored the germline mutation.
In conclusion, our case report highlight the importance of genetic testing in the molecular diagnosis of PBMAH. Genetic screening in related family members will find out asymptomatic variant carriers to guide life-long follow-up.
原发性双侧结节性肾上腺皮质增生症(PBMAH)是一种罕见的肾上腺库欣综合征形式。双侧肾上腺组织的缓慢进展性扩张通常持续数十年,导致由于慢性轻度皮质醇增多症而导致发病较晚且病情严重。约 20-50%的病例是由富含角蛋白重复蛋白 5(ARMC5)基因突变引起的。
一名 51 岁男性因严重糖尿病、耐药性高血压、向心性肥胖和水肿而入院。在确定促肾上腺皮质激素和皮质醇水平、地塞米松抑制试验和腹部增强 CT 扫描后,诊断为 PBMAH。患者的代谢紊乱在序贯双侧腹腔镜肾上腺切除术联合激素替代治疗后显著改善。桑格测序显示 ARMC5 c.967C>T(p.Gln323Ter)的胚系无义突变。在两个切除的结节中,有一个检测到 ARMC5 的第二个体细胞错义突变,反映了肿瘤发生的二次打击模型。对其两个明显健康的后代进行常规基因检测,发现两个女儿和一个儿子中有一个携带胚系突变。
总之,本病例报告强调了遗传检测在 PBMAH 分子诊断中的重要性。对相关家族成员进行遗传筛查将发现无症状的变异携带者,以指导终身随访。